Status:
COMPLETED
Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO
Lead Sponsor:
Mansoura University
Collaborating Sponsors:
Ahmed Mohamed Elshal
Conditions:
Overactive Bladder
Urinary Incontinence, Urge
Eligibility:
MALE
50+ years
Phase:
NA
Brief Summary
comparing the outcome of low-intensity shock wave therapy (Li-SWT) versus solifenacin on persistent storage symptoms after transurethral surgery for benign prostatic obstruction (BPO)
Detailed Description
Benign prostatic hyperplasia (BPH) is a common cause of lower urinary tract symptoms (LUTS) in aging men including both voiding and storage symptoms. After prostatectomy, 20-30% of the patients still ...
Eligibility Criteria
Inclusion
- Patients have to fulfill all the following criteria to be included in the study:
- Ability to give informed consent and reply to questionnaires.
- Average urgency episodes per 24 hrs ≥ 1 and average daytime frequency ≥ 8 during the baseline 3-day voiding diary.
- Relief of BOO as proved by non-invasive uroflowmetry, pressure flow study (PFS) or urethrocystoscopy.
Exclusion
- Patients who have any of the following will be excluded from the study:
- Untreated UTI.
- BOO such as bladder neck contracture (BNC), residual obstructing adenoma or urethral stricture.
- Neurogenic lower urinary tract dysfunction (LUTD).
- Uncontrolled diabetes mellitus.
- Depression or any psychogenic disorders.
- Prior radiation therapy to the pelvic area.
- History of prostate cancer, bladder tumor or intravesical Bacillus Calmette Guerin (BCG) therapy.
- Poor coagulopathy.
- Severe cardiovascular disease.
Key Trial Info
Start Date :
July 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 21 2022
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT04437108
Start Date
July 4 2020
End Date
July 21 2022
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology center
Al Mansurah, Egypt, 35516